Hadean Ventures crosses 5% ownership threshold in Oncoinvent

Hadean Ventures AS and its wholly-owned subsidiary HVentures AB have announced the acquisition of shares in Oncoinvent AS, leading to their collective holdings surpassing the 5% flagging threshold under Norwegian securities law. The transaction, which occurred on October 29, 2025, resulted from a merger.

Before this transaction, funds managed by Hadean Ventures AS and HVentures AB held 0 shares in Oncoinvent. Following the merger, their combined stake now stands at 15,438,716 shares, representing 9.85% of Oncoinvent's total 156,641,128 shares. This significant increase in ownership triggers a mandatory disclosure requirement.

The reporting entities, Hadean Ventures AS and HVentures AB, have consolidated their holdings for reporting purposes in accordance with Section 4-3 of the Norwegian Securities Trading Act. The previous total number of shares in Oncoinvent was 39,087,116 before the merger-related changes.